368 related articles for article (PubMed ID: 22591344)
1. Functional genomics- and network-driven systems biology approaches for pharmacogenomics and toxicogenomics.
Yang X; Zhang B; Zhu J
Curr Drug Metab; 2012 Sep; 13(7):952-67. PubMed ID: 22591344
[TBL] [Abstract][Full Text] [Related]
2. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: a systems approach.
Wang L
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):3-22. PubMed ID: 20836007
[TBL] [Abstract][Full Text] [Related]
4. Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
Talwar P; Sinha J; Grover S; Rawat C; Kushwaha S; Agarwal R; Taneja V; Kukreti R
Mol Neurobiol; 2016 Sep; 53(7):4833-64. PubMed ID: 26351077
[TBL] [Abstract][Full Text] [Related]
5. Chemical genomics and medicinal systems biology: chemical control of genomic networks in human systems biology for innovative medicine.
Kim TK
J Biochem Mol Biol; 2004 Jan; 37(1):53-8. PubMed ID: 14761303
[TBL] [Abstract][Full Text] [Related]
6. Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example.
Mas S; Gassó P; Lafuente A
Pharmacogenomics; 2015 Nov; 16(17):1975-88. PubMed ID: 26556470
[TBL] [Abstract][Full Text] [Related]
7. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in asthma therapy: where are we and where do we go?
Park HW; Tantisira KG; Weiss ST
Annu Rev Pharmacol Toxicol; 2015; 55():129-47. PubMed ID: 25292431
[TBL] [Abstract][Full Text] [Related]
9. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
Aardema MJ; MacGregor JT
Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
[TBL] [Abstract][Full Text] [Related]
10. Integrated approaches to functionally characterize novel factors in lipoprotein metabolism.
Runz H
Curr Opin Lipidol; 2012 Apr; 23(2):104-10. PubMed ID: 22327609
[TBL] [Abstract][Full Text] [Related]
11. Systems genetics approaches to understand complex traits.
Civelek M; Lusis AJ
Nat Rev Genet; 2014 Jan; 15(1):34-48. PubMed ID: 24296534
[TBL] [Abstract][Full Text] [Related]
12. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
13. Computational tools for discovery and interpretation of expression quantitative trait loci.
Wright FA; Shabalin AA; Rusyn I
Pharmacogenomics; 2012 Feb; 13(3):343-52. PubMed ID: 22304583
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
Low SK; Takahashi A; Mushiroda T; Kubo M
Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
[TBL] [Abstract][Full Text] [Related]
15. Application and interpretation of genome-wide association (GWA) studies for informing pharmacogenomic research - examples from the field of age-related macular degeneration.
SanGiovanni JP; Rosen R; Kaushal S
Curr Mol Med; 2014; 14(7):814-32. PubMed ID: 25109799
[TBL] [Abstract][Full Text] [Related]
16. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
[TBL] [Abstract][Full Text] [Related]
17. From systems biology and functional genomics to personalized health. 5th Biologie Prospective Santorini Conference, Island of Santorini, Greece, September 30-October 2, 2010.
Drug Metabol Drug Interact; 2011; 26(1):41-2. PubMed ID: 21417796
[No Abstract] [Full Text] [Related]
18. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
Sookoian S; Pirola CJ
World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
[TBL] [Abstract][Full Text] [Related]
19. Towards structural systems pharmacology to study complex diseases and personalized medicine.
Xie L; Ge X; Tan H; Xie L; Zhang Y; Hart T; Yang X; Bourne PE
PLoS Comput Biol; 2014 May; 10(5):e1003554. PubMed ID: 24830652
[TBL] [Abstract][Full Text] [Related]
20. Epistasis--the essential role of gene interactions in the structure and evolution of genetic systems.
Phillips PC
Nat Rev Genet; 2008 Nov; 9(11):855-67. PubMed ID: 18852697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
